AffiCELL® SH-SY5Y Cells
CAT# AFG-ADX-001
Size: 1 Vial
Application:
Derived from bone marrow biopsy-derived SK-N-SH cells, the SH-SY5Y cell line has undergone three rounds of cloning. Notably, SH-SY5Y cells exhibit dopamine-beta-hydroxylase activity and possess the capability to convert glutamate to gamma-aminobutyric acid (GABA). Moreover, they demonstrate tumorigenic potential in nude mice, typically forming tumors within a span of 3 to 4 weeks.
Organism
Homo sapiens, human.
Disease
Neuroblastoma.
Morphology
Epithelial.
Medium
Ham's F12-formulated EMEM (1:1) + 15% FBS.
Patient
Female, Age: 4 years.
Tissue
Brain.